Literature DB >> 8530498

Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/GRO alpha gene requires both NF-kappa B and novel constitutive factors.

L D Wood1, A Richmond.   

Abstract

Melanoma growth stimulatory activity (MGSA)/growth regulated (GRO) and interleukin-8 (IL-8) are highly related chemokines that have a causal role in melanoma progression. Expression of these chemokines is similar in that both require the NF-kappa B element and additional regions such as the CAAT/enhancer binding protein (C/EBP) element of the IL-8 promoter. The constitutive and cytokine IL-1-induced promoter activity of the chemokine MGSA/GRO alpha in normal retinal pigment epithelial and the Hs294T melanoma cells is partially regulated through the NF-kappa B element, which binds both NF-kappa B p50 and RelA (NF-kappa B p65) homodimers and heterodimers. Mutational analysis of the MGSA/GRO alpha promoter reveals that, in addition to the NF-kappa B element, the immediate upstream region (IUR) is necessary for basal expression in retinal pigment epithelial and Hs294T cells. Gel mobility shift and UV cross-linking analyses demonstrate that several constitutive DNA binding proteins interact with the IUR. Although this region has sequence similarity to the several transcription factor elements including C/EBP, the IUR includes sequences that have no similarity to previously identified enhancer regions. Furthermore, RelA transactivates through either the NF-kappa B element or the IUR, suggesting a putative interaction between NF-kappa B and this novel complex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530498     DOI: 10.1074/jbc.270.51.30619

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.

Authors:  Sergey V Novitskiy; Michael W Pickup; Agnieszka E Gorska; Philip Owens; Anna Chytil; Mary Aakre; Huiyun Wu; Yu Shyr; Harold L Moses
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

2.  Control of chemokine production at the blood-retina barrier.

Authors:  I J Crane; C A Wallace; S McKillop-Smith; J V Forrester
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

3.  PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.

Authors:  Venkateshwar G Keshamouni; Douglas A Arenberg; Raju C Reddy; Michael J Newstead; Shalini Anthwal; Theodore J Standiford
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

4.  Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression.

Authors:  C M Thorpe; W E Smith; B P Hurley; D W Acheson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  The role of CDP in the negative regulation of CXCL1 gene expression.

Authors:  C Nirodi; J Hart; P Dhawan; N S Moon ; A Nepveu; A Richmond
Journal:  J Biol Chem       Date:  2001-05-22       Impact factor: 5.157

6.  A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets.

Authors:  Yingjun Su; Katayoun I Amiri; Linda W Horton; Yingchun Yu; Gregory D Ayers; Elizabeth Koehler; Mark C Kelley; Igor Puzanov; Ann Richmond; Jeffrey A Sosman
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

Review 7.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

Review 8.  Nf-kappa B, chemokine gene transcription and tumour growth.

Authors:  Ann Richmond
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

Review 9.  Role of CXCL1 in tumorigenesis of melanoma.

Authors:  Punita Dhawan; Ann Richmond
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

10.  Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection.

Authors:  M Thapa; D J J Carr
Journal:  Open Immunol J       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.